跳至主要内容
临床试验/CTRI/2020/06/026229
CTRI/2020/06/026229招募中2 期

Effect of Malla Chandrodaya & Ashtadashang ghan vati in Patients with mild to moderate Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infections

Dr Namrata Joshi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i. Laboratory-confirmed mild to moderate symptomatic cases of COVID-19 above
  • between 18years irrespective of sex will be included.
  • ii. Patients able to take medicines orally.
  • iii. Patients willing to provide signed informed consent may be included in the Inclusion

排除标准

  • i. Cases of severe vomiting which would affect oral administration of medicine difficult.
  • ii. Cases of respiratory failure and requiring mechanical ventilation
  • iii. Combined organ failure requiring ICU monitoring.
  • iv. Any other condition, which as per the investigator would jeopardize the outcome of

研究者

发起方
Dr Namrata Joshi

相似试验